查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1402922

药物洗脱球囊市场 - 2023-2031 年全球产业分析、规模、份额、成长、趋势与预测

Drug Eluting Balloon Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 212 Pages | 商品交期: 2-10个工作天内

价格

药物洗脱球囊市场 - 报告范围

TMR 关于全球药物洗脱球囊市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球药物洗脱球囊的收入2017-2031年期间的市场，考虑2023年为基准年，2031年为预测年。报告也提供了2023年至2031年全球药物洗脱球囊市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解药物洗脱球囊市场。

市场概况
2023年市场价值 5.711 亿美元
2031 年市场价值 10 亿美元
CAGR 7.1%

该报告深入研究了全球药物洗脱球囊市场的竞争格局。全球药物洗脱球囊市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球药物洗脱球囊市场参与者的属性。

目录

第 1 章：执行摘要

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 市场区隔
  • 概述
  • 市场动态
  • 2023-2031年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • COVID-19 大流行对该行业的影响

第 6 章：市场分析与预测：依产品分类

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按产品，2023-2031
    • 冠状动脉
    • 週边
    • 其他的
  • 市场吸引力：依产品分类

第 7 章：市场分析与预测：依技术分类

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依技术分类，2023-2031
    • 帕科卡斯
    • 自由派克
    • 运输公司
    • 耐杜拉外套
    • 其他的
  • 市场吸引力：依技术分类

第 8 章：全球市场分析与预测：按最终用户

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2023-2031
    • 医院及门诊手术中心
    • 导管实验室
    • 其他的
  • 市场吸引力：按最终用户划分

第 9 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2023-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力：按地区

第 10 章：北美市场分析与预测

第 11 章：欧洲市场分析与预测

第 12 章：亚太市场分析与预测

第 13 章：拉丁美洲市场分析与预测

第 14 章：中东和非洲市场分析与预测

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • Bayer AG
    • Medtronic
    • B. Braun Melsungen AG
    • Cook Medical, Inc.
    • Boston Scientific Corporation
    • Becton, Dickson and Company
    • EuroCor
    • Terumo Corporation
    • Koninklijke Philips NV
Product Code: TMRGL2321

Drug Eluting Balloon Market - Scope of Report

TMR's report on the global drug eluting balloon market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global drug eluting balloon market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global drug eluting balloon market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the drug eluting balloon market.

Market Snapshot
Market Value in 2023US$ 571.1 Mn
Market Value in 2031US$ 1 Bn
CAGR7.1%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global drug eluting balloon market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global drug eluting balloon market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global drug eluting balloon market.

The report delves into the competitive landscape of the global drug eluting balloon market. Key players operating in the global drug eluting balloon market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global drug eluting balloon market profiled in this report.

Key Questions Answered in Global drug eluting balloon Market Report:

  • What is the sales/revenue generated by drug eluting balloon across all regions during the forecast period?
  • What are the opportunities in the global drug eluting balloon market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Drug Eluting Balloon Market - Research Objectives and Research Approach

The comprehensive report on the global drug eluting balloon market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global drug eluting balloon market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global drug eluting balloon market.

Table of Contents

1. Executive Summary

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Drug Eluting Balloon Market

4. Market Overview

  • 4.1. Market Segmentation
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Drug Eluting Balloon Market Analysis and Forecast, 2023-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. COVID-19 Pandemic Impact on Industry

6. Drug Eluting Balloon Market Analysis and Forecast, by Product

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2023-2031
    • 6.3.1. Coronary Drug Eluting Balloon
    • 6.3.2. Peripheral Drug Eluting Balloon
    • 6.3.3. Others
  • 6.4. Market Attractiveness, by Product

7. Drug Eluting Balloon Market Analysis and Forecast, by Technology

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technology, 2023-2031
    • 7.3.1. Paccocath
    • 7.3.2. FreePac
    • 7.3.3. TransPax
    • 7.3.4. EnduraCoat
    • 7.3.5. Others
  • 7.4. Market Attractiveness, by Technology

8. Global Drug Eluting Balloon Market Analysis and Forecast, by End-user

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2023-2031
    • 8.3.1. Hospitals and Ambulatory Surgery Centers
    • 8.3.2. Cath Labs
    • 8.3.3. Others
  • 8.4. Market Attractiveness, by End-user

9. Global Drug Eluting Balloon Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2023-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness, by Region

10. North America Drug Eluting Balloon Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2023-2031
    • 10.2.1. Coronary Drug Eluting Balloon
    • 10.2.2. Peripheral Drug Eluting Balloon
    • 10.2.3. Others
  • 10.3. Market Attractiveness, by Product
  • 10.4. Market Value Forecast, by Technology, 2023-2031
    • 10.4.1. Paccocath
    • 10.4.2. FreePac
    • 10.4.3. TransPax
    • 10.4.4. EnduraCoat
    • 10.4.5. Others
  • 10.5. Market Attractiveness, by Technology
  • 10.6. Market Value Forecast, by End-user, 2023-2031
    • 10.6.1. Hospitals and Ambulatory Surgery Centers
    • 10.6.2. Cath Labs
    • 10.6.3. Others
  • 10.7. Market Attractiveness, by End-user
  • 10.8. Market Value Forecast, by Country, 2023-2031
    • 10.8.1. U.S.
    • 10.8.2. Canada
  • 10.9. Market Attractiveness Analysis
    • 10.9.1. By Product
    • 10.9.2. By Technology
    • 10.9.3. By End-user
    • 10.9.4. By Country

11. Europe Drug Eluting Balloon Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2023-2031
    • 11.2.1. Coronary Drug Eluting Balloon
    • 11.2.2. Peripheral Drug Eluting Balloon
    • 11.2.3. Others
  • 11.3. Market Attractiveness, by Product
  • 11.4. Market Value Forecast, by Technology, 2023-2031
    • 11.4.1. Paccocath
    • 11.4.2. FreePac
    • 11.4.3. TransPax
    • 11.4.4. EnduraCoat
    • 11.4.5. Others
  • 11.5. Market Attractiveness, by Technology
  • 11.6. Market Value Forecast, by End-user, 2023-2031
    • 11.6.1. Hospitals and Ambulatory Surgery Centers
    • 11.6.2. Cath Labs
    • 11.6.3. Others
  • 11.7. Market Attractiveness, by End-user
  • 11.8. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 11.8.1. Germany
    • 11.8.2. U.K.
    • 11.8.3. France
    • 11.8.4. Italy
    • 11.8.5. Spain
    • 11.8.6. Rest of Europe
  • 11.9. Market Attractiveness Analysis
    • 11.9.1. By Product
    • 11.9.2. By Technology
    • 11.9.3. By End-user
    • 11.9.4. By Country/Sub-region

12. Asia Pacific Drug Eluting Balloon Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2023-2031
    • 12.2.1. Coronary Drug Eluting Balloon
    • 12.2.2. Peripheral Drug Eluting Balloon
    • 12.2.3. Others
  • 12.3. Market Attractiveness, by Product
  • 12.4. Market Value Forecast, by Technology, 2023-2031
    • 12.4.1. Paccocath
    • 12.4.2. FreePac
    • 12.4.3. TransPax
    • 12.4.4. EnduraCoat
    • 12.4.5. Others
  • 12.5. Market Attractiveness, by Technology
  • 12.6. Market Value Forecast, by End-user, 2023-2031
    • 12.6.1. Hospitals and Ambulatory Surgery Centers
    • 12.6.2. Cath Labs
    • 12.6.3. Others
  • 12.7. Market Attractiveness, by End-user
  • 12.8. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 12.8.1. China
    • 12.8.2. Japan
    • 12.8.3. India
    • 12.8.4. Australia & New Zealand
    • 12.8.5. Rest of Asia Pacific
  • 12.9. Market Attractiveness Analysis
    • 12.9.1. By Product
    • 12.9.2. By Technology
    • 12.9.3. By End-user
    • 12.9.4. By Country/Sub-region

13. Latin America Drug Eluting Balloon Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2023-2031
    • 13.2.1. Coronary Drug Eluting Balloon
    • 13.2.2. Peripheral Drug Eluting Balloon
    • 13.2.3. Others
  • 13.3. Market Attractiveness, by Product
  • 13.4. Market Value Forecast, by Technology, 2023-2031
    • 13.4.1. Paccocath
    • 13.4.2. FreePac
    • 13.4.3. TransPax
    • 13.4.4. EnduraCoat
    • 13.4.5. Others
  • 13.5. Market Attractiveness, by Technology
  • 13.6. Market Value Forecast, by End-user, 2023-2031
    • 13.6.1. Hospitals and Ambulatory Surgery Centers
    • 13.6.2. Cath Labs
    • 13.6.3. Others
  • 13.7. Market Attractiveness, by End-user
  • 13.8. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 13.8.1. Brazil
    • 13.8.2. Mexico
    • 13.8.3. Rest of Latin America
  • 13.9. Market Attractiveness Analysis
    • 13.9.1. By Product
    • 13.9.2. By Technology
    • 13.9.3. By End-user
    • 13.9.4. By Country/Sub-region

14. Middle East & Africa Drug Eluting Balloon Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2023-2031
    • 14.2.1. Coronary Drug Eluting Balloon
    • 14.2.2. Peripheral Drug Eluting Balloon
    • 14.2.3. Others
  • 14.3. Market Attractiveness, by Product
  • 14.4. Market Value Forecast, by Technology, 2023-2031
    • 14.4.1. Paccocath
    • 14.4.2. FreePac
    • 14.4.3. TransPax
    • 14.4.4. EnduraCoat
    • 14.4.5. Others
  • 14.5. Market Attractiveness, by Technology
  • 14.6. Market Value Forecast, by End-user, 2023-2031
    • 14.6.1. Hospitals and Ambulatory Surgery Centers
    • 14.6.2. Cath Labs
    • 14.6.3. Others
  • 14.7. Market Attractiveness, by End-user
  • 14.8. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 14.8.1. GCC Countries
    • 14.8.2. South Africa
    • 14.8.3. Rest of Middle East & Africa
  • 14.9. Market Attractiveness Analysis
    • 14.9.1. By Product
    • 14.9.2. By Technology
    • 14.9.3. By End-user
    • 14.9.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. Bayer AG
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Medtronic
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. B. Braun Melsungen AG
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Cook Medical, Inc.
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Boston Scientific Corporation
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Becton, Dickson and Company
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. EuroCor
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Terumo Corporation
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Koninklijke Philips N.V.
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview

List of Tables

  • Table 01: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031
  • Table 02: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 03: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 04: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Region, 2023-2031
  • Table 05: North America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Country, 2023-2031
  • Table 06: North America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031
  • Table 07: North America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 08: North America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 09: Europe Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 10: Europe Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031
  • Table 11: Europe Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 12: Europe Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user 2023-2031
  • Table 13: Asia Pacific Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 14: Asia Pacific Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031
  • Table 15: Asia Pacific Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 16: Asia Pacific Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 17: Latin America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 18: Latin America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031
  • Table 19: Latin America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 20: Latin America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user 2023-2031
  • Table 21: Middle East & Africa Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 22: Middle East & Africa Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031
  • Table 23: Middle East & Africa Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 24: Middle East & Africa Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user 2023-2031

List of Figures

  • Figure 01: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 02: Global Drug Eluting Balloon Market Value Share, by Product, 2022
  • Figure 03: Global Drug Eluting Balloon Market Value Share, by Technology, 2022
  • Figure 04: Global Drug Eluting Balloon Market Value Share, by End-user, 2022
  • Figure 05: Global Drug Eluting Balloon Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 06: Global Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 07: Global Drug Eluting Balloon Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 08: Global Drug Eluting Balloon Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 09: Global Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 10: Global Drug Eluting Balloon Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 11: Global Drug Eluting Balloon Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 12: Global Drug Eluting Balloon Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 13: North America Drug Eluting Balloon Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 14: North America Drug Eluting Balloon Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 15: North America Drug Eluting Balloon Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 16: North America Drug Eluting Balloon Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 17: North America Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 18: North America Drug Eluting Balloon Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 19: North America Drug Eluting Balloon Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 20: North America Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 21: North America Drug Eluting Balloon Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 22: Europe Drug Eluting Balloon Market Value (US$ Mn) Forecast, 2022-2031
  • Figure 23: Europe Drug Eluting Balloon Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 24: Europe Drug Eluting Balloon Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 25: Europe Drug Eluting Balloon Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 26: Europe America Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 27: Europe Drug Eluting Balloon Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 28: Europe Drug Eluting Balloon Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 29: Europe Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 30: Europe Drug Eluting Balloon Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 31: Asia Pacific Drug Eluting Balloon Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 32: Asia Pacific Drug Eluting Balloon Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 33: Asia Pacific Drug Eluting Balloon Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 34: Asia Pacific Drug Eluting Balloon Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 35: Asia Pacific America Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 36: Asia Pacific Drug Eluting Balloon Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 37: Asia Pacific Drug Eluting Balloon Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 38: Asia Pacific Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 39: Asia Pacific Drug Eluting Balloon Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 40: Latin America Drug Eluting Balloon Market Value (US$ Mn) Forecast, 2022-2031
  • Figure 41: Latin America Drug Eluting Balloon Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 42: Latin America Drug Eluting Balloon Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 43: Latin America Drug Eluting Balloon Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 44: Latin America Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 45: Latin America Drug Eluting Balloon Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 46: Latin America Drug Eluting Balloon Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 47: Latin America Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 48: Latin America Drug Eluting Balloon Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 49: Middle East & Africa Drug Eluting Balloon Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 50: Middle East & Africa Drug Eluting Balloon Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 51: Middle East & Africa America Drug Eluting Balloon Market Value Share Analysis, by Product, 2022-2031
  • Figure 52: Middle East & Africa America Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 53: Middle East & Africa Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 54: Middle East & Africa Drug Eluting Balloon Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 55: Global Drug Eluting Balloon Market Share Analysis, by Company (2022)